ReWalk Robotics Ltd. (NASDAQ:RWLK)’s share price was down 2% during mid-day trading on Thursday . The company traded as low as $5.73 and last traded at $5.86, with a volume of 81,431 shares traded. The stock had previously closed at $5.98.

A number of equities analysts have issued reports on RWLK shares. Canaccord Genuity reissued a “buy” rating on shares of ReWalk Robotics in a research report on Sunday, August 7th. Piper Jaffray Cos. started coverage on shares of ReWalk Robotics in a research report on Friday, July 15th. They set an “overweight” rating and a $10.00 price target for the company. Zacks Investment Research raised shares of ReWalk Robotics from a “hold” rating to a “buy” rating and set a $11.00 price target for the company in a research report on Tuesday, May 10th. Finally, Jefferies Group reissued a “buy” rating and set a $16.00 price target on shares of ReWalk Robotics in a research report on Sunday, May 8th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $12.80.

The firm’s 50-day moving average is $6.60 and its 200-day moving average is $8.19. The stock’s market capitalization is $71.77 million.

ReWalk Robotics (NASDAQ:RWLK) last announced its quarterly earnings data on Thursday, August 4th. The medical device company reported ($0.64) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.53) by $0.11. The firm earned $0.82 million during the quarter, compared to analyst estimates of $1.95 million. ReWalk Robotics’s quarterly revenue was up 34.4% compared to the same quarter last year. On average, equities research analysts anticipate that ReWalk Robotics Ltd. will post ($2.34) earnings per share for the current year.

In related news, Director Jeff Dykan sold 11,370 shares of the company’s stock in a transaction that occurred on Wednesday, June 1st. The stock was sold at an average price of $7.74, for a total value of $88,003.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Wayne Weisman sold 100,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 16th. The shares were sold at an average price of $6.37, for a total value of $637,000.00. The disclosure for this sale can be found here.

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.